Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Shimodaira, Masanori ^a,b   Niwa, Tomohiro ^a   Nakajima, Koji ^a   Kobayashi, Mutsuhiro ^a   Hanyu, Norinao ^a   Nakayama, Tomohiro ^b  

^a Iida Municipal Hospital   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Fasting plasma glucose; Hyperglycemia; Mean platelet volume; Prediabetes

Indexed keywords

GLUCOSE; LIPID;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; CONFOUNDING VARIABLE; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; THROMBOCYTE VOLUME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PLATELETS; CELL SIZE; FASTING; FEMALE; GLYCEMIC INDEX; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDIES;

EID: 84872134290     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-14     Document Type: Article

References (36)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(1):S62-S69. 3006051, 21193628, American Diabetes Association.
2. American Diabetes Association Summary of revisions to the 2011 clinical practice recommendations. Diabetes Care 2011, 34(1):S3. 3006057, 21193626, American Diabetes Association.
3. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011, 108:3B-24B. 10.1016/j.amjcard.2011.03.013, 21802577.
4. Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ 2012, 344:e3564. 10.1136/bmj.e3564, 3370083, 22677795.
5. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009, 63:1509-1515. 10.1111/j.1742-1241.2009.02070.x, 19769707.
6. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002, 13:301-306. 10.1080/095371002220148332, 12189016.
7. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998, 19:80-84. 10.1053/euhj.1997.0747, 9503179.
8. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007, 120:245-250. 10.1016/j.thromres.2006.10.005, 17145074.
9. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004, 15:475-478. 10.1080/0953710042000267707, 15763888.
10. Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in type 2 diabetic patients. J Diabetes Complications 2004, 18:173-176. 10.1016/S1056-8727(02)00282-9, 15145330.
11. Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications 2009, 23:89-94. 10.1016/j.jdiacomp.2008.01.006, 18358749.
12. Shah B, Sha D, Xie D, Mohler ER, Berger JS. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the national health and nutrition examination survey, 1999-2004. Diabetes Care 2012, 35:1074-1078. 10.2337/dc11-1724, 22410814.
13. Muscari A, De Pascalis S, Cenni A, Ludovico C, Castaldini N, Antonelli S, Bianchi G, Magalotti D, Zoli M. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008, 99:1079-1084.
14. Kim JH, Kang SB, Kang JI, Kim JW, Kim SY, Bae HY. The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a korean general population: gender differences. Platelets 2012, in press.
15. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
16. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2008, 31(1):S55-60. American Diabetes Association.
17. Sundaram M, Mohanakrishnan J, Murugavel KG, Shankar EM, Solomon S, Srinivas CN, Solomon SS, Pulimi S, Piwowar-Manning E, Dawson S, et al. Ethnic variation in certain hematological and biochemical reference intervals in a south Indian healthy adult population. Eur J Intern Med 2008, 19:46-50. 10.1016/j.ejim.2007.06.010, 18206601.
18. Cao X, Xie X, Zhou J, Yang P, Wang Y, Chen Z. Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80 545 participants from china. Hypertens Res 2012, 35:903-908. 10.1038/hr.2012.62, 22573201.
19. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006, 17:67-69. 10.1080/09537100500220729, 16308190.
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(1):S5-20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
21. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85. 10.1016/S0168-8227(01)00365-5, 11755481.
22. Forouhi NG, Balkau B, Borch-Johnsen K, Dekker J, Glumer C, Qiao Q, Spijkerman A, Stolk R, Tabac A, Wareham NJ. The threshold for diagnosing impaired fasting glucose: a position statement by the european diabetes epidemiology group. Diabetologia 2006, 49:822-827.
23. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010, 55:1310-1317. 10.1016/j.jacc.2009.10.060, 20338491.
24. Bostan F, Coban E. The relationship between levels of von willebrand factor and mean platelet volume in subjects with isolated impaired fasting glucose. Med Sci Monit 2011, 17:PR1-4.
25. Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prev Cardiol 2012, 19:755-764. 10.1177/1741826711409327, 21551215.
26. Shaye K, Amir T, Shlomo S, Yechezkel S. Fasting glucose levels within the high normal range predict cardiovascular outcome. Am Heart J 2012, 164:111-116. 10.1016/j.ahj.2012.03.023, 22795290.
27. Martyn CN, Matthews DM, Popp-Snijders C, Tucker J, Ewing DJ, Clarke BF. Effects of sorbinil treatment on erythrocytes and platelets of persons with diabetes. Diabetes Care 1986, 9:36-39. 10.2337/diacare.9.1.36, 3948646.
28. Watanabe Y, Kawada M, Kobayashi B. Effect of insulin on murine megakaryocytopoiesis in a liquid culture system. Cell Struct Funct 1987, 12:311-316. 10.1247/csf.12.311, 3304669.
29. Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, et al. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol 2012, 11:11. 10.1186/1475-2840-11-11, 3295671, 22292925.
30. Park Y, Harris WS. Dose-dependent effects of n-3 polyunsaturated fatty acids on platelet activation in mildly hypertriglyceridemic subjects. J Med Food 2009, 12:809-813. 10.1089/jmf.2008.1097, 19735181.
31. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets 2007, 18:212-216. 10.1080/09537100600975362, 17497433.
32. Varol E, Akcay S, Ozaydin M, Erdogan D, Dogan A, Altinbas A. Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease. J Cardiol 2010, 56:154-158. 10.1016/j.jjcc.2010.03.005, 20430587.
33. Kebapcilar L, Taner CE, Kebapcilar AG, Sari I. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet 2009, 280:187-193. 10.1007/s00404-008-0884-0, 19107500.
34. Rerkpattanapipat P, D'Agostino RB, Link KM, Shahar E, Lima JA, Bluemke DA, Sinha S, Herrington DM, Hundley WG. Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the multi-ethnic study of atherosclerosis. Diabetes 2009, 58:946-953. 10.2337/db08-1192, 2661581, 19136657.
35. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002, 19:708-723.
36. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity New criteria for 'obesity disease' in Japan. Circ J 2002, 66:987-992. 10.1253/circj.66.987, 12419927, Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity.